Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CYCLACEL PHARMACEUTICALS INC Financial Overview

  • Income Statement: CYCC

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 877,000.00 129,000.00 748,000.00 85.29%
    Gross Profit -1.41 M -995,000.00 -419,000.00 29.63%
    Net Income Before Extra Items/Preferred Div -40.39 M -24.05 M -16.33 M 40.44%
    Operating Income -33.78 M -30.98 M -2.79 M 8.27%
  • Cash Flow: CYCC

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -1.24 M 32.21 M -33.45 M 2,701.62%
    Net Cash Flow - Investing -27.34 M 22.69 M -50.04 M 183.00%
    Net Cash Flow/Operating Activities -29.90 M -23.14 M -6.76 M 22.62%
  • Balance Sheet: CYCC

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 30.96 M 75.91 M -44.96 M -145.22%
    Total Liabilities 10.32 M 17.94 M -7.63 M -73.95%
    Shareholders Equity 20.64 M 57.97 M -37.33 M -180.83%
  • Key Ratios / Statistics: CYCC

    • Valuation

      Price/Earnings (TTM) -0.21
      Price/Sales (TTM) 9.79
      Price/Book (MRQ) -1.67
      Price/Cash Flow (TTM) -2.32
    • Profitability

      Gross Margin -161.23
      Operating Margin -3,851.20
      Profit Margin -4,605.02
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.16
      Current Ratio (MRQ) 1.74
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -217.14
      Return on Assets (TTM) -77.84
      Return on Investments (TTM) -102.21